Article
Targeting c-Kit mutations: basic science to novel therapies.
Leukemia research - 1 May 2004
Sattler Martin, Salgia Ravi
Abstract excerpt
The Kit receptor tyrosine kinase is a transmembrane receptor that is expressed in a variety of different tissues and mediates pleiotropic biological effects through its ligand stem cell factor (SCF). Sporadic mutations of Kit as well as autocrine/paracrine activation mechanisms of the SCF/Kit pathway have been implicated in a variety of malignancies, where its primary contribution to metastases is in enhancing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
